GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group AS (OCSE:PEG) » Definitions » Institutional Ownership

Pharma Equity Group AS (OCSE:PEG) Institutional Ownership : 0.18% (As of Dec. 13, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group AS Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Pharma Equity Group AS's institutional ownership is 0.18%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Pharma Equity Group AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Pharma Equity Group AS's Float Percentage Of Total Shares Outstanding is 0.00%.


Pharma Equity Group AS Institutional Ownership Historical Data

The historical data trend for Pharma Equity Group AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group AS Institutional Ownership Chart

Pharma Equity Group AS Historical Data

The historical data trend for Pharma Equity Group AS can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 0.19 0.19 0.19 0.17 0.17 0.16 0.16 0.16 0.18 0.18

Pharma Equity Group AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Pharma Equity Group AS Business Description

Traded in Other Exchanges
N/A
Address
Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970
Pharma Equity Group AS is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develop technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement. Its drug candidates include RNX-011, RNX-021, RNX-022, RNX-023, RNX-041, and RNX-051 .